Author: Jakob Emerson

CMS has finalized its plan to cover the controversial Alzheimer's disease drug Aduhelm under Medicare.

Frank Micciche is vice president of public policy and external relations at the National Committee for Quality Assurance. He spoke with Becker's to explain why the NCQA believes recent star ratings changes by CMS to the weighting of patient experience…

From several disagreements over reimbursement rates to millions in unpaid claims, these five contracts between payers and providers were recently terminated:

It's been 100 days since the No Surprises Act went into effect, but America's Health Insurance Plans says additional regulations are still needed.

CMS will pay for a second COVID-19 booster shot for people covered under Medicare and Medicaid.

California health officials are investigating Centene for unspecified reasons following its acquisition of Magellan Health, the administrator of Medi-Cal prescriptions, according to Kaiser Health News.

Payers and healthcare organizations publicly announced their support of President Joe Biden's proposal to expand the Affordable Care Act to include more families.

Becker's calculated the payer mix within the nation's top ranked hospitals to determine the share of their patients covered under commercial plans, Medicare, Medicaid, Medicare Advantage, uninsured/bad debt and charity care.

CMS released its final 2023 Medicare Advantage capitation and Part C and D rate announcement April 5, and now America's Health Insurance Plans is raising some concerns.

The Affordable Care Act saw enrollment grow by 21 percent this year, and now some payers are cutting the commissions of private brokers, according to Fortune.